Strive Inc. has disclosed a proposed transaction with Semler Scientific, Inc. The deal is expected to involve the issuance of additional shares of Strive’s Class A common stock and aims to create strategic and financial benefits for both companies. The companies anticipate the integration process may present challenges such as potential dilution, possible changes in customer or employee relationships, and the need to manage ongoing business operations during the transition. The timing of the closing and the ultimate impact on the combined company’s financial performance remain subject to various market and operational factors, and there is no guarantee that anticipated cost savings or strategic gains will be realized as planned.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strive Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9627137) on January 16, 2026, and is solely responsible for the information contained therein.